John P. Butler, CEO and President of Akebia Therapeutics ($AKBA), bought shares once on the open market in the last year, totaling about $86,600 with the latest purchase on March 4, 2026. This ranks 2,525th among nearly 5,000 insiders, well below the $1.5 million average. He sold shares four times for nearly $474,400, most recently on February 2, 2026, ranking 6,574th out of about 11,700 insiders versus the $8.6 million average.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | P | Common Stock | 69270 | $1.25 | 3,526,992.0000 | 274,372,722 | 2.00% | 0.03% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 46660 | $1.39 | 3,577,117.0000 | 274,372,722 | 1.29% | 0.02% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 83689 | $1.39 | 3,457,722.0000 | 274,372,722 | 2.36% | 0.03% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Common Stock | 175250 | $1.41 | 3,541,411.0000 | 274,372,722 | 5.21% | 0.06% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 114891 | $1.39 | 3,366,161.0000 | 274,372,722 | 3.30% | 0.04% |
| Feb. 2, 2026 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 96065 | $1.39 | 3,481,052.0000 | 274,372,722 | 2.69% | 0.04% |
| Jan. 30, 2026 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Stock Option (Right to buy) | 1115000 | $0.00 | 1,115,000.0000 | 274,372,722 | 9999.99% | 0.41% |
| Jan. 30, 2026 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Common Stock | 743000 | $0.00 | 3,623,777.0000 | 274,372,722 | 25.79% | 0.27% |
| March 3, 2025 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 46409 | $1.83 | 2,877,777.0000 | 210,946,658 | 1.59% | 0.02% |
| Feb. 3, 2025 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 46268 | $2.10 | 3,022,168.0000 | 210,946,658 | 1.51% | 0.02% |
| Jan. 31, 2025 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Performance Stock Units | 350500 | $0.00 | 350,500.0000 | 210,946,658 | 9999.99% | 0.17% |
| Jan. 31, 2025 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Stock Option (Right to buy) | 1051400 | $0.00 | 1,051,400.0000 | 210,946,658 | 9999.99% | 0.50% |
| Jan. 31, 2025 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Common Stock | 701000 | $0.00 | 3,068,436.0000 | 210,946,658 | 29.61% | 0.33% |
| Feb. 3, 2025 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 97982 | $2.10 | 2,924,186.0000 | 210,946,658 | 3.24% | 0.05% |
| Feb. 29, 2024 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 46570 | $1.58 | 2,364,436.0000 | 187,465,448 | 1.93% | 0.02% |
| Feb. 27, 2024 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 37733 | $1.52 | 2,411,006.0000 | 187,465,448 | 1.54% | 0.02% |
| Feb. 1, 2024 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 46489 | $1.68 | 2,448,739.0000 | 187,465,448 | 1.86% | 0.02% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Stock Option (Right to buy) | 905200 | $0.00 | 905,200.0000 | 187,465,448 | 9999.99% | 0.48% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Common Stock | 603500 | $0.00 | 2,495,228.0000 | 187,465,448 | 31.90% | 0.32% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 6370 | $0.88 | 1,888,728.0000 | 0 | 0.34% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 38259 | $0.88 | 1,942,337.0000 | 0 | 1.93% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 47239 | $0.88 | 1,895,098.0000 | 0 | 2.43% | 0.00% |
| Feb. 27, 2023 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | S | Common Stock | 38632 | $0.81 | 1,980,596.0000 | 0 | 1.91% | 0.00% |
| Jan. 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Stock Option (Right to buy) | 875000 | $0.00 | 875,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Common Stock | 293125 | $0.00 | 2,019,228.0000 | 0 | 16.98% | 0.00% |
| Jan. 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Butler John P. | CEO and President | A | Stock Appreciation Right | 635313 | $0.00 | 635,313.0000 | 0 | 9999.99% | 0.00% |